Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 151

1.

EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis.

Mygland A, Ljøstad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I; European Federation of Neurological Societies.

Eur J Neurol. 2010 Jan;17(1):8-16, e1-4. doi: 10.1111/j.1468-1331.2009.02862.x. Epub 2009 Nov 23.

PMID:
19930447
2.

CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Ljøstad U, Mygland A.

J Neurol. 2008 May;255(5):732-7. doi: 10.1007/s00415-008-0785-y. Epub 2008 Mar 17. Erratum in: J Neurol. 2008 May;255(5):782. J Neurol. 2008 May;255(5):782.

PMID:
18344056
3.

Cerebrospinal fluid chemokine CXCL13 in the diagnosis of neuroborreliosis in children.

Sillanpää H, Skogman BH, Sarvas H, Seppälä IJ, Lahdenne P.

Scand J Infect Dis. 2013 Jul;45(7):526-30. doi: 10.3109/00365548.2013.776700. Epub 2013 Mar 22.

PMID:
23521134
4.

[CXCL13: a biomarker for acute Lyme neuroborreliosis: investigation of the predictive value in the clinical routine].

Rupprecht TA, Lechner C, Tumani H, Fingerle V.

Nervenarzt. 2014 Apr;85(4):459-64. doi: 10.1007/s00115-014-4020-z. German.

PMID:
24682168
5.

Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection.

Bremell D, Mattsson N, Edsbagge M, Blennow K, Andreasson U, Wikkelsö C, Zetterberg H, Hagberg L.

BMC Neurol. 2013 Jan 7;13:2. doi: 10.1186/1471-2377-13-2.

6.

Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial.

Ljøstad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, Mygland A.

Lancet Neurol. 2008 Aug;7(8):690-5. doi: 10.1016/S1474-4422(08)70119-4. Epub 2008 Jun 21. Erratum in: Lancet Neurol. 2008 Aug;7(8):675.

PMID:
18567539
7.

Clinical usefulness of intrathecal antibody testing in acute Lyme neuroborreliosis.

Ljøstad U, Skarpaas T, Mygland A.

Eur J Neurol. 2007 Aug;14(8):873-6.

PMID:
17662007
8.

Antibiotics for the neurological complications of Lyme disease.

Cadavid D, Auwaerter PG, Rumbaugh J, Gelderblom H.

Cochrane Database Syst Rev. 2016 Dec 8;12:CD006978. doi: 10.1002/14651858.CD006978.pub2. Review.

PMID:
27931077
9.

The diagnostic spectrum in patients with suspected chronic Lyme neuroborreliosis--the experience from one year of a university hospital's Lyme neuroborreliosis outpatients clinic.

Djukic M, Schmidt-Samoa C, Nau R, von Steinbüchel N, Eiffert H, Schmidt H.

Eur J Neurol. 2011 Apr;18(4):547-55. doi: 10.1111/j.1468-1331.2010.03229.x. Epub 2010 Oct 27.

PMID:
20977545
10.

Oral doxycycline for Lyme neuroborreliosis with symptoms of encephalitis, myelitis, vasculitis or intracranial hypertension.

Bremell D, Dotevall L.

Eur J Neurol. 2014 Sep;21(9):1162-7. doi: 10.1111/ene.12420. Epub 2014 Mar 29.

PMID:
24684211
11.

Evaluation of two assays for CXCL13 analysis in cerebrospinal fluid for laboratory diagnosis of Lyme neuroborreliosis.

Henningsson AJ, Gyllemark P, Lager M, Skogman BH, Tjernberg I.

APMIS. 2016 Nov;124(11):985-990. doi: 10.1111/apm.12596. Epub 2016 Sep 20.

12.

Antibodies to decorin-binding protein B (DbpB) in the diagnosis of Lyme neuroborreliosis in children.

Sillanpää H, Skogman BH, Sarvas H, Seppälä IJ, Lahdenne P.

Int J Infect Dis. 2014 Nov;28:160-3. doi: 10.1016/j.ijid.2014.07.006. Epub 2014 Oct 12.

13.

Cerebrospinal fluid findings in adults with acute Lyme neuroborreliosis.

Djukic M, Schmidt-Samoa C, Lange P, Spreer A, Neubieser K, Eiffert H, Nau R, Schmidt H.

J Neurol. 2012 Apr;259(4):630-6. doi: 10.1007/s00415-011-6221-8. Epub 2011 Sep 6.

14.

CSF B - lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Ljøstad U, Mygland Å.

J Neurol. 2008 May;255(5):782. doi: 10.1007/s00415-008-0974-8. Epub 2008 Mar 17.

PMID:
27517589
15.

Intravenous ceftriaxone compared with oral doxycycline for the treatment of Lyme neuroborreliosis.

Borg R, Dotevall L, Hagberg L, Maraspin V, Lotric-Furlan S, Cimperman J, Strle F.

Scand J Infect Dis. 2005;37(6-7):449-54.

PMID:
16012005
16.

Lyme neuroborreliosis: a treatable cause of acute ocular motor disturbances in children.

Correll MH, Datta N, Arvidsson HS, Melsom HA, Thielberg AK, Bjerager M, Brodsky MC, Saunte JP.

Br J Ophthalmol. 2015 Oct;99(10):1401-4. doi: 10.1136/bjophthalmol-2015-306855. Epub 2015 Apr 13.

PMID:
25868792
17.

CXCL13 and neopterin concentrations in cerebrospinal fluid of patients with Lyme neuroborreliosis and other diseases that cause neuroinflammation.

Hytönen J, Kortela E, Waris M, Puustinen J, Salo J, Oksi J.

J Neuroinflammation. 2014 Jun 11;11:103. doi: 10.1186/1742-2094-11-103.

18.

Clinical aspects of neuroborreliosis and post-Lyme disease syndrome in adult patients.

Pfister HW, Rupprecht TA.

Int J Med Microbiol. 2006 May;296 Suppl 40:11-6. Epub 2006 Mar 9. Review.

PMID:
16524775
19.

Management of neuroborreliosis in European adult patients.

Ljøstad U, Henriksen TH.

Acta Neurol Scand Suppl. 2008;188:22-8. doi: 10.1111/j.1600-0404.2008.01027.x. Review.

PMID:
18439217
20.

A case of hemifacial paresis in a patient with Lyme neuroborreliosis treated with antibiotics in whom Borrelia meningitis developed.

Shimizu H, Haratani K, Miyazaki M, Kakehi Y, Nagami S, Katanami Y, Kawabata H, Takahashi N.

Rinsho Shinkeigaku. 2016 Jul 28;56(7):495-8. doi: 10.5692/clinicalneurol.cn-000880. Epub 2016 Jun 30.

PMID:
27356734

Supplemental Content

Support Center